Paracel Explorer

Dernière publication·Octobre 2026

Dovato

Dolutegravirum / Lamivudinum — cpr pell 50/300 mg

ViiV Healthcare GmbH

Swissmedic67313

Dossier21042

Remboursement

QP 10%

Modifications (10)